Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Cannassure Therapeutics Ltd
  6. News
  7. Summary
    CSURE   IL0001110134

CANNASSURE THERAPEUTICS LTD

(CSURE)
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

DanCann Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended 31 December 2020

02/26/2021 | 02:00am EDT

DanCann Pharma A/S reported earnings results for the fourth quarter and full year ended 31 December 2020. For the fourth quarter, the company reported operating loss (LBIT) of DKK 2,721 compared to DKK 493 a year ago. Loss per share was DKK 0.07. For the full year, the company reported operating loss (LBIT) of DKK 5,870 compared to DKK 627 a year ago. Loss per share was DKK 0.48.


ę S&P Capital IQ 2021
All news about CANNASSURE THERAPEUTICS LTD
05/06LIPIDOR : publishes interim report for Q1 2021
AQ
02/26DanCann Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended ..
CI
2020DanCann Pharma A/S enter exclusive agreement with Cannassure Therapeutics to be multina..
CI
2020Cannassure Therapeutics Ltd Announces Successful Completion of Feasibility Study for th..
CI
2019CANNASSURE COMPLETED THE ACQUISITION : DCI-M) in a reverse merger.
CI
2018CANNASSURE AGREED TO ACQUIRE DIRECT : DCI-M) in a reverse merger.
CI
More news
Financials
Sales 2020 3,50  1,09  1,09 
Net income 2020 -28,5 M -8,92 M -8,92 M
Net Debt 2020 8,33 M 2,60 M 2,60 M
P/E ratio 2020 -2,44x
Yield 2020 -
Capitalization 35,5 M 11,1 M 11,1 M
EV / Sales 2019 -
EV / Sales 2020 23 980 148x
Nbr of Employees 44
Free-Float 49,1%
Chart CANNASSURE THERAPEUTICS LTD
Duration : Period :
Cannassure Therapeutics Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Ran Amir Chief Executive Officer & Director
Adi Noyfeld Chief Financial Officer
Ido Nehushtan Chairman
Bezalel Livne Independent External Director
Nir Peles Director & Vice President-Business Development